Center-Authored Papers

Filters: Author is Tolar, Jakub  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2011
Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R et al..  2011.  Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network,. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):291-9. Abstract
Eapen M, Le Rademacher J, Antin JH, Champlin RE, Carreras J, Fay J, Passweg JR, Tolar J, Horowitz MM, Marsh JCW et al..  2011.  Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.. Blood. 118(9):2618-21. Abstract
Tolar J, Adair JE, Antoniou M, Bartholomae CC, Becker PS, Blazar BR, Bueren J, Carroll T, Cavazzana-Calvo M, Clapp WD et al..  2011.  Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.. Molecular therapy : the journal of the American Society of Gene Therapy. 19(7):1193-8. Abstract
2012
Tolar J, Deeg HJ, Arai S, Horwitz M, Antin JH, McCarty JM, Adams RH, Ewell M, Leifer ES, Gersten ID et al..  2012.  Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(7):1007-11. Abstract
Tolar J, Becker PS, Bueren J, Clapp WD, Hanenberg H, de Heredia CD, Kiem H-P, Navarro S, Qasba P, Río P et al..  2012.  Gene Therapy for Fanconi Anemia: One Step Closer to the Clinic.. Human gene therapy. 23(2):141-144. Abstract
2013
Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E et al..  2013.  Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(8):1238-43. Abstract
Aging
Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R et al..  2011.  Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network,. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):291-9. Abstract
Anemia, Aplastic
Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R et al..  2011.  Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network,. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):291-9. Abstract
Biological Specimen Banks
Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R et al..  2011.  Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network,. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):291-9. Abstract
Biomedical Research
Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R et al..  2011.  Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network,. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):291-9. Abstract
Bone Marrow Transplantation
Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R et al..  2011.  Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network,. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):291-9. Abstract
Center-Authored Paper
Tolar J, Deeg HJ, Arai S, Horwitz M, Antin JH, McCarty JM, Adams RH, Ewell M, Leifer ES, Gersten ID et al..  2012.  Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(7):1007-11. Abstract
Tolar J, Adair JE, Antoniou M, Bartholomae CC, Becker PS, Blazar BR, Bueren J, Carroll T, Cavazzana-Calvo M, Clapp WD et al..  2011.  Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.. Molecular therapy : the journal of the American Society of Gene Therapy. 19(7):1193-8. Abstract
Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E et al..  2013.  Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(8):1238-43. Abstract
Tolar J, Becker PS, Bueren J, Clapp WD, Hanenberg H, de Heredia CD, Kiem H-P, Navarro S, Qasba P, Río P et al..  2012.  Gene Therapy for Fanconi Anemia: One Step Closer to the Clinic.. Human gene therapy. 23(2):141-144. Abstract
Clinical Research Division
Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R et al..  2011.  Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network,. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):291-9. Abstract
Eapen M, Le Rademacher J, Antin JH, Champlin RE, Carreras J, Fay J, Passweg JR, Tolar J, Horowitz MM, Marsh JCW et al..  2011.  Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.. Blood. 118(9):2618-21. Abstract
Gadalla SM, Sales-Bonfim C, Carreras J, Alter BP, Antin JH, Ayas M, Bodhi P, Davis J, Davies SM, Deconinck E et al..  2013.  Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(8):1238-43. Abstract
Tolar J, Becker PS, Bueren J, Clapp WD, Hanenberg H, de Heredia CD, Kiem H-P, Navarro S, Qasba P, Río P et al..  2012.  Gene Therapy for Fanconi Anemia: One Step Closer to the Clinic.. Human gene therapy. 23(2):141-144. Abstract
Tolar J, Adair JE, Antoniou M, Bartholomae CC, Becker PS, Blazar BR, Bueren J, Carroll T, Cavazzana-Calvo M, Clapp WD et al..  2011.  Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.. Molecular therapy : the journal of the American Society of Gene Therapy. 19(7):1193-8. Abstract
Tolar J, Deeg HJ, Arai S, Horwitz M, Antin JH, McCarty JM, Adams RH, Ewell M, Leifer ES, Gersten ID et al..  2012.  Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(7):1007-11. Abstract
Clinical Trials as Topic
Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R et al..  2011.  Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network,. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):291-9. Abstract
Collaborative Data Services Core Facility
Tolar J, Deeg HJ, Arai S, Horwitz M, Antin JH, McCarty JM, Adams RH, Ewell M, Leifer ES, Gersten ID et al..  2012.  Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(7):1007-11. Abstract
Humans
Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R et al..  2011.  Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network,. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):291-9. Abstract
Immunosuppression
Pulsipher MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R et al..  2011.  Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network,. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):291-9. Abstract